Japanese researchers have recently begun a clinical study of the flu drug Avigan to see if it can cure a tick-transmitted infectious disease that has a relatively high fatality rate and no effective treatment. Avigan, developed by a unit of Tokyo-based Fujifilm Holdings Corp., is ...
France says results of trials in Guinea of anti-Ebola drug encouraging
France said on Wednesday the first trials of a drug to treat Ebola in Guinea had been encouraging and appeared to accelerate the recovery process of patients, President Francois Hollande's office said in a statement. Trials of an experimental Japanese drug — Avigan, or favipiravir ...
Medical charities say they have started trials of untested drug treatments on Ebola patients in Liberia and Guinea for the first time in an effort to control an epidemic that has killed more than 8,000 people in the region. The World Health Organization gave its ...
Flu drug aimed at Ebola may also fight norovirus, study finds
An experimental Japanese flu drug that has garnered headlines because of its potential to fight Ebola may also work against norovirus, the winter vomiting bug, British researchers said on Tuesday. As with Ebola, the research is still at an early stage but a study in ...
No biohazard facilities in Japan can handle Ebola
Despite government assurances that Japan can handle an Ebola outbreak, there are no biosafety facilities rated to handle the deadly virus and 400 SDF troops are stationed near Congo.
Fujifilm share jumps as Ebola patient given drug leaves hospital
Fujifilm Holdings Corp. shares rose to their highest level in more than six years in Tokyo trading Monday after a French Ebola patient, who was given its Avigan drug with another experimental treatment, was sent home from the hospital. The company's shares rose 2.8 percent ...
Japan to help fight Ebola outbreak if requested
If requested, the government will provide to the World Health Organization and other parties an unapproved medicine that might help combat the deadly Ebola virus, Chief Cabinet Secretary Yoshihide Suga says.
